Key result
Depletion of MAVS in human mesenchymal stem cells accelerated cellular senescence and mitochondrial dysfunction, which was alleviated by replenishing MAVS or OPA1.
Why the study?
It was unknown whether the mitochondrial antiviral signaling protein (MAVS) also regulates human stem cell senescence.
Does MAVS regulate human stem cell senescence and mitochondrial homeostasis?
Population
MAVS-knockout human stem cell models including human mesenchymal stem cells
Comparison
MAVS or OPA1 depletion vs replenishment in MAVS-knockout cells
Design
Preclinical in vitro laboratory study using CRISPR/Cas9-mediated gene editing
Authors
Loading...
MAVS-OPA1 axis may modulate stem cell senescence; leaves open any role in human regenerative or aging therapies.
Does MAVS regulate human stem cell senescence and mitochondrial homeostasis?
MAVS plays an uncanonical role in safeguarding mitochondrial homeostasis and antagonizing human stem cell senescence through interaction with OPA1.
Wang et al. (2023) studied Cellular senescence. MAVS-knockout via CRISPR/Cas9 vs. Wild-type or replenishment of MAVS/OPA1 was evaluated on Mitochondrial structural integrity, functional homeostasis, and cellular senescence. Depletion of MAVS in human mesenchymal stem cells accelerated cellular senescence and mitochondrial dysfunction, which was alleviated by replenishing MAVS or OPA1.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: